Aerosol Therapy in Obese COPD Patients.

Inclusion Criteria

• •HEALTHY, non obese
• •no history of respiratory disease
• •non smokers
• •self declared sedentary
• •Forced expiratory volume at first second (FEV1) equal or higher than 80% of predicted
• •Forced Vital capacity (FVC) equal or higher than 80% of predicted;
• •FEV1/FVC higher than 70% of predicted.
• •BMI lower than 30 kg/m2
• •HEALTHY, obese
• •no history of respiratory disease
• •non smokers
• •self declared sedentary
• •Forced expiratory volume at first second (FEV1) equal or higher than 80% of predicted
• •Forced Vital capacity (FVC) equal or higher than 80% of predicted
• •FEV1/FVC higher than 70% of predicted.
• •BMI equal or higher than 30 kg/m2
• •COPD participants, non obese
• •ex smokers
• •clinical stability (six previous weeks)
• •FEV1 lower than 80% of predicted.
• •FEV1/FVC lower than 70 % post bronchodilator.
• •No cardiopulmonary diseases (self declared)
• •BMI lower than 30 kg/m2
• •COPD participants, obese
• •ex smokers
• •clinical stability (six previous weeks)
• •FEV1 lower than 80% of predicted.
• •FEV1/FVC lower than 70 % post bronchodilator.
• •No cardiopulmonary diseases (self declared)
• •BMI equal or higher than 30 kg/m2